Related Experiment Video
Updated: Aug 30, 2026

Isolation of Primary Patient-specific Aortic Smooth Muscle Cells and Semiquantitative Real-time Contraction Measurements In Vitro
Published on: February 15, 2022
Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit
Eugenio Stabile1, Yi Fu Zhou, Motoyasu Saji
1Cardiovascular Research Institute, Washington Hospital Center, 110 Irving St NW, 4B-1, Washington, DC 20010, USA. geko50@katamail.com
Abstract:
Constitutive activation of serine/threonine kinase Akt causes uncontrolled cell-cycle progression in different cell types and in malignancy. To investigate how Akt activation modulates cell-cycle progression in vascular smooth muscle cells (SMCs) in vitro and in the intact animal, we inhibited Akt-dependent signaling by adenovirus-mediated transfection of a dominant-negative Akt mutant (AA-Akt). We observed reduced proliferation rate (P<0.01), DNA synthesis (P<0.01), and a significant arrest in G1/S exit (P<0.01) both in vitro in response to serum stimulation and in vivo after vascular injury. In vivo transfection of the balloon-injured vessel with AA-Akt reduced SMC proliferation, resulting in decreased neointima compared with control virus (P<0.01). These effects were at least in part modulated, both in vitro and in vivo, by increased p21Cip1 expression, as demonstrated by lack of effect of AA-Akt on cell proliferation in p21-/- mouse SMCs. In conclusion, this study demonstrates that Akt-dependent signaling enhances cell-cycle progression of nontransformed SMCs in vitro and in response to vascular injury in the intact animal. These results suggest a role for Akt signaling in modulating the response of normal tissues to stress and the response of the arterial wall to acute and possibly repetitive injuries that ultimately contribute to restenosis and atherosclerosis.
Insights
Akt signaling promotes cell-cycle progression in vascular smooth muscle cells (SMCs). Inhibiting Akt with dominant-negative Akt mutant (AA-Akt) reduced SMC proliferation and neointima formation after vascular injury, mediated by p21Cip1.
Area of Science:
- Cell Biology
- Molecular Biology
- Cardiovascular Research
Background:
- Constitutive activation of serine/threonine kinase Akt leads to uncontrolled cell-cycle progression.
- Akt signaling plays a role in various cell types and in malignancy.
- Understanding Akt's role in vascular smooth muscle cells (SMCs) is crucial for cardiovascular health.
Purpose of the Study:
- To investigate how Akt activation modulates cell-cycle progression in vascular smooth muscle cells (SMCs) in vitro and in vivo.
- To determine the effect of inhibiting Akt-dependent signaling on SMC proliferation and vascular injury response.
- To elucidate the role of p21Cip1 in mediating Akt's effects on SMCs.
Main Methods:
- Adenovirus-mediated transfection of a dominant-negative Akt mutant (AA-Akt) to inhibit Akt signaling.
- In vitro studies involving serum stimulation of SMCs.
- In vivo studies using balloon-induced vascular injury in animal models.
- Analysis of cell proliferation, DNA synthesis, G1/S phase arrest, and neointima formation.
- Experiments utilizing p21-/- mouse SMCs to assess the role of p21Cip1.
Main Results:
- Inhibition of Akt signaling with AA-Akt significantly reduced SMC proliferation rate and DNA synthesis in vitro (P<0.01).
- AA-Akt induced a significant arrest in G1/S phase exit in SMCs both in vitro and in vivo (P<0.01).
- In vivo transfection with AA-Akt reduced SMC proliferation and neointima formation after vascular injury (P<0.01).
- The effects of AA-Akt were partially mediated by increased p21Cip1 expression, as AA-Akt had no effect on p21-/- mouse SMC proliferation.
Conclusions:
- Akt-dependent signaling enhances cell-cycle progression of nontransformed SMCs in vitro.
- Akt signaling plays a significant role in the SMC response to vascular injury in vivo.
- Akt signaling modulates normal tissue responses to stress and arterial wall responses to injury, potentially contributing to restenosis and atherosclerosis.
- p21Cip1 is a key mediator of Akt's effects on SMC proliferation and vascular injury response.
More Related Videos
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
10:57Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta
Published on: September 12, 2017
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Cell Cycle Control System
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Regulation of Angiogenesis and Blood Supply